GlobalData
GlobalData

Rebecca Panks

  • Home
  • Author: Rebecca Panks

Dexamethasone and remdesivir could compliment each other, says GlobalData

After receiving a world-first approval by the UK Government, following groundbreaking data showing it can reduce COVID-19 deaths among hospitalized patients, the inexpensive and widely available corticosteroid dexamethasone has been getting significant attention. While data supporting dexamethasone’s efficacy seem clear, the magnitude of its benefit remains modest. Further, additional studies are warranted so as to […]
Read more

Airbus to minimise exposure to COVID-19 disruptions by outsourcing production of A320neo components, says GlobalData

Following the news that Airbus is scrapping plans to produce A320neo nacelles and engines in house; Nicolas Jouan, Aerospace and Defense Analyst at GlobalData, a leading data and analytics company, offers his view on Airbus’ situation: “The news that Airbus was giving up on its plans to take over the production of A320neo nacelles and […]
Read more

Gilead’s inhaled remdesivir to commence Phase I trials, but new formulation may be required, says GlobalData

Following Gilead’s announcement that it will begin Phase I clinical trials for inhaled remdesivir in healthy volunteers, data and analytics company GlobalData anticipates that a new route of administration will specifically target patients with mild to moderate COVID-19 infection and will be administered via a nebuliser so that patients can  self-administer away from hospital. GlobalData […]
Read more

North American integrated oil & gas operators with highly diversified portfolios have better chances to navigate COVID-19 crisis, says GlobalData

A combination of asset type and geographical diversification can determine the impact COVID-19 has on North American oil and gas companies. Other characteristics such as debt-to-equity ratio, cashflow sensitivity to price changes and announced capex cuts play their part, but companies that are limited geographically have more difficulty in re-adjusting plans, says GlobalData, a leading […]
Read more

Healthcare sector witnessed 6.8% decline in deal activity during week ended 21 June, says GlobalData

The number of deals announced in the global healthcare sector (including pharmaceuticals and medical equipment) declined by 6.8% during the week ended 21 June 2020, compared to the previous week, according to GlobalData’s deals database. Aurojyoti Bose, Lead Analyst at GlobalData, comments: “Although the healthcare sector has been relatively resilient compared to other sectors amid […]
Read more

Abbott’s revenue growth to continue during COVID-19 thanks to diabetes care device, says GlobalData

Following the news that Abbott’s Q1 worldwide sales increased 2.5% despite the negative business impact of COVID-19; Dara Lo, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “Abbott’s diverse product portfolio provides some resilience during the COVID-19 pandemic compared with other companies. Even though Abbott’s Core Laboratory Diagnostics showed […]
Read more

Mixer’s demise was inevitable but Microsoft will continue to challenge Amazon and Google, says GlobalData

Following the news that Microsoft is closing its Mixer game streaming platform and partnering with Facebook Gaming; Rupantar Guha, Senior Analyst of Thematic Research at GlobalData, a leading data and analytics company, offers his view: “Microsoft’s decision to close Mixer is a surprise but was inevitable as the platform was struggling due to limited content […]
Read more
1 51 52 53 54 55 77